Basic & Clinical Medicine ›› 2017, Vol. 37 ›› Issue (2): 261-264.
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Supported by:
Abstract: Thrombin activatable fibrinolysis inhibitor (TAFI) is a kind of plasma enzymes that can be activated by thrombin. TAFI regulates blood coagulation and fibrinolysis and has a strong fibrinolytic and anti-inflammatory activity. Its inhibitor is expected to avoid the risk of bleeding when thrombolytic recanalization. Also, studies found that TAFI played an important role in the development of cerebral thrombosis; atherosclerosis and so on.
Key words: thrombin activation of fibrinolysis inhibitor (TAFI), cerebral thrombosis, cardiovascular disease
CLC Number:
R966
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2017/V37/I2/261